Frequency of apolipoprotein E (APOE) allele types in patients with Chlamydia-associated arthritis and other arthritides

Microbial Pathogenesis

Volumn 26, Issue 1, 1999, Pages 35-43

  Gérard, Hervé C ^a   Wang, Geng Feng ^b   Balin, Brian J ^c   Schumacher, H Ralph ^b   Hudson, Alan P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein E; Arthritis; Chlamydia pneumoniae; Synovial bacteria

Indexed keywords

APOLIPOPROTEIN E; BACTERIAL DNA; MESSENGER RNA; NUCLEIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ARTHRITIS; CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; SYNOVIUM;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA PNEUMONIAE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; RICKETTSIALES;

EID: 0032968170     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1998.0242     Document Type: Article

References (37)

1. Wilkins RF, Arnett FC, Bitter T, et al. Reiter's syndrome: Evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981; 24: 844-9.
2. Klippel JN, Weyand CM, Wortmann RL. Primer of the Rheumatic Diseases, 11th Edition. Atlanta: Arthritis Foundation Press, 1997.
3. Braun J, Tuszewski M, Eggens U, et al. Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997; 24: 1092-100.
4. Branigan PJ, Gérard HC, Saaibi DL, et al. Comparison of synovial tissue and synovial fluid as source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction. Arthritis Rheum 1996; 39: 1740-6.
5. Gran JT, Hjetland R, Andraessen AH. Pneumonia, myocarditis, and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993; 22: 43-4.
6. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae-a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53: 100-5.
7. Beaudreuil J, Hayem G, Meyer O, Khan MR Reactive arthritis ascribed to Chlamydia pneumoniae. Rev Rheum 1995; 3: 222-4.
8. Wilkinson NZ, Kingsley GH, Sieper J, Braun J, Ward ME. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum 1998; 41: 845-54.
9. Köhler L, Zeidler H, Hudson AP. Etiologic agents in reactive arthritis, their molecular biology and phagocyte-host interactions. Baillière's Clin Rheumatol 1998; in press.
10. Sieper J, Kingsley GH, Märker-Hermann E. Aetiological agents and immune mechanisms in enterogenic reactive arthritis. Baillière's Clin Rheumatol 1996; 10: 105-21.
11. Kingsley G, Sieper J. Current perspectives in reactive arthritis. Immunol Today 1993; 14: 387-91.
12. Sieper J, Braun J. Pathogenesis of spondylarthropathies. Arthritis Rheum 1995; 38: 1547-54.
13. Hahn DL, Dodge RS, Golubjatnikov R. Association of Chlamydia pneumoniae infection with wheezing, asthmatic bronchitis, adult-onset asthma. J Am Med Assoc 1991; 266: 225-30.
14. Grayston JT, Aldous MB, Easton A. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168: 1231-5.
15. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscl Thromb 1991; 11: 547-51.
16. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 1995; 92: 6911-14.
17. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995; 172: 585-8.
18. Balin BJ, Gérard HC, Arking ET, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbial Immunol 1998; 187: 23-42.
19. Roses AD. Apolipoprotein E alleles as risk factor in Alzheimer's disease. Ann Rev Med 1996; 47: 387-400.
20. Schellenberg GD. Genetic dissection of Alzheimer's disease, a heterogeneous disorder. Proc Natl Acad Sci (USA) 1995; 92: 8552-9.
21. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985; 76: 1501-13.
22. Basu SK, Ho YK, Brown MS, Bilheimer DW, Anderson RG, Goldstein JL. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem 1982; 257: 9788-94.
23. Newman TC, Dawson PA, Rudel LL, Williams DL. Quantitation of apolipoprotein E mRNA in the liver and peripheral tissues of nonhuman primates. J Biol Chem 1985; 260: 2452-7.
24. HAsegawa H, Nishi S-I, Ito S, et al. High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis Rheum 1996; 39: 1728-32.
25. Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998; 177: 725-9.
26. Ordovas JM, Litwack-Klein L, Wilson PWF, Schafer MM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987; 28: 371-80.
27. Moazad TC, Kuo CC, Patton DL, Grayston JT, Campell LA. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Pathol 1996; 148: 667-76.
28. Beutler AM, Whittum-Hudson JA, Nanagara R, Schumacher HR, Hudson AP. Intracellular location of inapparently infecting chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res 1994; 13: 163-71.
29. Beutler AM, Schumacher HR, Whittum-Hudson JA, Salameh W, Hudson AP. Case report: In situ hybridization for detection of inapparent infection with Chlamydia trachomatis in synovial tissue of a patient with Reiter's syndrome. Am J Med Sci 1995; 310: 206-13.
30. Jenkinson ML, Bliss MR, Brain AT, Scott DL. Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol 1989; 28: 86-8.
31. Myllykangas-Luosujärvi R, Isomäki H. Alzheimer's disease and rheumatoid arthritis. Br J Rheumatol 1994; 33: 501-2.
32. Beard CM, Kokman E, Kurland LT. Rheumatoid arthritis and susceptibility to Alzheimer's disease. Lancet 1991; 337: 1426.
33. Breitner JC. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Ann Rev Med 1996; 47: 401-11.
34. Schumacher HR, Kulka JB. Needle biopsy of the synovial membrane: Experience with the Parker-Pearson technique. N Engl J Med 1972; 286: 416-19.
35. Gérard HC, Branigan PJ, Schumacher HR, Hudson AP. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 1998; 25: 734-42.
36. Li F, Bulbul R, Schumacher HR, et al. Molecular detection of bacterial DNA in venereal-associated arthritis. Arthritis Rheum 1996; 39: 950-8.
37. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8.